See every side of every news story
Get Started
SubscribeLogin
Israel-Hamas Conflict
Tariffs
Donald Trump
Volodymyr Zelenskyy
Canadian Economy
US Politics
Ukraine War
US Economy
European Union
Social Media
The Oscars
Artificial Intelligence
Baseball
Published • loading... • Updated

Breakthrough! Exciting interim Phase II Data of LP-003 in CSU released by Longbio at AAAAI 2025

Summary by Missoulian
SAN DIEGO, March 2, 2025 /PRNewswire/ -- Longbio Pharma (Suzhou) Co., Ltd. (referred to as "Longbio"), a leading biotech company dedicated to developing innovative biologic treatments for allergy, respiratory, dermatology, hematology, ophthalmology, and other autoimmune and rare diseases, proudly announced…

8 Articles

All
Left
Center
4
Right
Longview Daily NewsLongview Daily News
+7 Reposted by 7 other sources

Breakthrough! Exciting interim Phase II Data of LP-003 in CSU released by Longbio at AAAAI 2025

SAN DIEGO, March 2, 2025 /PRNewswire/ -- Longbio Pharma (Suzhou) Co., Ltd. (referred to as "Longbio"), a leading biotech company dedicated to developing innovative biologic treatments for allergy, respiratory, dermatology, hematology, ophthalmology, and other autoimmune and rare diseases, proudly announced…

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Missoulian broke the news in Missoula, United States on Sunday, March 2, 2025.
Sources are mostly out of (0)

Similar News Topics

San Diego

San Diego

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.

News
For You
Search
BlindspotLocal